There are only two types of investors (short & long term) and SCRC can be a winner for each of them. But, for anyone who truly understands SCRC and has watched the revenues increasing each month, there is no reason to sell at this time. We have two more weeks to go in July and based on the past five record breaking months of performance I see Main Ave reporting revenues in the $3M rate, a $36 annual run rate. I don't think we'll see 50-60% increasing anymore. I'm not being negative at all. Based on my own DD conducted a few months ago, I reported a healthy compound pharmacy should report $4 - $4.5M in monthly revenues. SCRC will definitely get there over the several months. These are exciting times for SCRC and for it's investors.